首页 > 最新文献

British medical bulletin最新文献

英文 中文
From the Archive 来自档案
2区 医学 Q1 Medicine Pub Date : 2023-03-01 DOI: 10.1093/bmb/ldad004
Journal Article From the Archive Get access British Medical Bulletin, Volume 145, Issue 1, March 2023, Page 5, https://doi.org/10.1093/bmb/ldad004 Published: 05 April 2023 Article history Received: 01 March 2023 Published: 05 April 2023
期刊文章从档案馆获取英国医学公报,第145卷,第1期,2023年3月,第5页,https://doi.org/10.1093/bmb/ldad004发布日期:2023年4月5日文章历史收到日期:2023年3月1日发布日期:2023年4月5日
{"title":"From the Archive","authors":"","doi":"10.1093/bmb/ldad004","DOIUrl":"https://doi.org/10.1093/bmb/ldad004","url":null,"abstract":"Journal Article From the Archive Get access British Medical Bulletin, Volume 145, Issue 1, March 2023, Page 5, https://doi.org/10.1093/bmb/ldad004 Published: 05 April 2023 Article history Received: 01 March 2023 Published: 05 April 2023","PeriodicalId":9280,"journal":{"name":"British medical bulletin","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134949126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical controversies and current concepts in Lisfranc injuries. Lisfranc损伤的外科争议和当前概念。
IF 6.7 2区 医学 Q1 Medicine Pub Date : 2022-12-12 DOI: 10.1093/bmb/ldac020
Raju Ahluwalia, Grace Yip, Martinus Richter, Nicola Maffulli

Introduction: Lisfranc injuries, not as rare as previously reported, range from ligamentous to complex fracture-dislocations. Anatomical studies have identified a complex of discrete structures, and defined the anatomical characteristics of the Lisfranc joint.

Sources of data: A narrative evidence-based review encompassed and analyzed published systematic reviews. Outcomes included clinical and surgical decision-making, including clinical-presentation, diagnosis, pathological-assessment, surgical-management techniques and indications, post-surgical care and comparative outcomes.

Areas of agreement: Better understanding of the Lisfranc complex anatomy aids surgical treatment and tactics. Prognosis is related to injury severity, estimated by the number of foot columns affected. Surgical outcome is determined by anatomical reduction for most fixation and fusion techniques. Appropriate treatment allows return to sport, improving outcome scores.

Areas of controversy: Identification of Lisfranc injuries may be improved by imaging modalities such as weight-bearing computer tomography. Recent evidence supports dorsal plate fixation as a result of better quality of reduction. In complex injuries, the use of combined techniques such as trans-articular screw and plate fixation has been associated with poorer outcomes, and fusion may instead offer greater benefits.

Growing points: Open reduction is mandatory if closed reduction fails, highlighting the importance of understanding surgical anatomy. If anatomical reduction is achieved, acute arthrodesis is a safe alternative to open reduction internal fixation in selected patients, as demonstrated by comparable outcomes in subgroup analysis.

Areas for developing research: The current controversies in surgical treatment remain around techniques and outcomes, as randomized controlled trials are infrequent.

前言:Lisfranc损伤,不像以前报道的那样罕见,范围从韧带到复杂的骨折脱位。解剖研究已经确定了一个复杂的离散结构,并确定了Lisfranc关节的解剖特征。数据来源:一项基于证据的叙述性综述,包含并分析了已发表的系统性综述。结果包括临床和手术决策,包括临床表现、诊断、病理评估、手术管理技术和适应症、术后护理和比较结果。共识领域:更好地了解Lisfranc复杂的解剖结构有助于手术治疗和策略。预后与损伤严重程度有关,根据受影响足柱的数量来估计。手术结果取决于大多数固定和融合技术的解剖复位。适当的治疗可以恢复运动,提高结果得分。争议领域:通过负重计算机断层扫描等成像方式可以改善对Lisfranc损伤的识别。最近的证据支持背钢板固定,因为复位质量更好。在复杂的损伤中,使用联合技术如经关节螺钉和钢板固定的预后较差,而融合可能提供更大的益处。生长点:如果闭合复位失败,则必须进行切开复位,这突出了了解外科解剖的重要性。亚组分析的可比结果表明,如果实现解剖复位,在选定的患者中,急性关节融合术是开放复位内固定的安全选择。发展研究领域:由于随机对照试验很少,目前在手术治疗方面的争议仍然围绕技术和结果。
{"title":"Surgical controversies and current concepts in Lisfranc injuries.","authors":"Raju Ahluwalia,&nbsp;Grace Yip,&nbsp;Martinus Richter,&nbsp;Nicola Maffulli","doi":"10.1093/bmb/ldac020","DOIUrl":"https://doi.org/10.1093/bmb/ldac020","url":null,"abstract":"<p><strong>Introduction: </strong>Lisfranc injuries, not as rare as previously reported, range from ligamentous to complex fracture-dislocations. Anatomical studies have identified a complex of discrete structures, and defined the anatomical characteristics of the Lisfranc joint.</p><p><strong>Sources of data: </strong>A narrative evidence-based review encompassed and analyzed published systematic reviews. Outcomes included clinical and surgical decision-making, including clinical-presentation, diagnosis, pathological-assessment, surgical-management techniques and indications, post-surgical care and comparative outcomes.</p><p><strong>Areas of agreement: </strong>Better understanding of the Lisfranc complex anatomy aids surgical treatment and tactics. Prognosis is related to injury severity, estimated by the number of foot columns affected. Surgical outcome is determined by anatomical reduction for most fixation and fusion techniques. Appropriate treatment allows return to sport, improving outcome scores.</p><p><strong>Areas of controversy: </strong>Identification of Lisfranc injuries may be improved by imaging modalities such as weight-bearing computer tomography. Recent evidence supports dorsal plate fixation as a result of better quality of reduction. In complex injuries, the use of combined techniques such as trans-articular screw and plate fixation has been associated with poorer outcomes, and fusion may instead offer greater benefits.</p><p><strong>Growing points: </strong>Open reduction is mandatory if closed reduction fails, highlighting the importance of understanding surgical anatomy. If anatomical reduction is achieved, acute arthrodesis is a safe alternative to open reduction internal fixation in selected patients, as demonstrated by comparable outcomes in subgroup analysis.</p><p><strong>Areas for developing research: </strong>The current controversies in surgical treatment remain around techniques and outcomes, as randomized controlled trials are infrequent.</p>","PeriodicalId":9280,"journal":{"name":"British medical bulletin","volume":"144 1","pages":"57-75"},"PeriodicalIF":6.7,"publicationDate":"2022-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10422072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Corrigendum to: Ethical and policy issues raised by uterus transplants. 更正:子宫移植引起的伦理和政策问题。
IF 6.7 2区 医学 Q1 Medicine Pub Date : 2022-12-12 DOI: 10.1093/bmb/ldaa020
Laura O'Donovan, Nicola Jane Williams, Stephen Wilkinson
{"title":"Corrigendum to: Ethical and policy issues raised by uterus transplants.","authors":"Laura O'Donovan, Nicola Jane Williams, Stephen Wilkinson","doi":"10.1093/bmb/ldaa020","DOIUrl":"10.1093/bmb/ldaa020","url":null,"abstract":"","PeriodicalId":9280,"journal":{"name":"British medical bulletin","volume":" ","pages":"92"},"PeriodicalIF":6.7,"publicationDate":"2022-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/bmb/ldaa020","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10339241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Workplace exposure to UV radiation and strategies to minimize cancer risk. 工作场所暴露于紫外线辐射和降低癌症风险的策略。
IF 6.7 2区 医学 Q1 Medicine Pub Date : 2022-12-12 DOI: 10.1093/bmb/ldac019
J W Cherrie, M P C Cherrie

Background: Workplace exposure to solar ultraviolet (UV) causes malignant melanoma and non-melanoma skin cancer. The evidence for beneficial effects of solar UV exposure in reducing the risks for other cancers is increasing. The intensity of UV radiation at the Earth's surface is dependent on latitude, but even in northern European countries exposure can be high enough for outdoor work to cause skin cancer.

Growing points: Awareness of the health risks and benefits of occupational solar UV exposure is poor. Actions to reduce the risk of skin cancer have been identified and employers should recognize their responsibility to actively manage these risks. There is evidence for reduced risks for breast, ovarian and colorectal cancer and possibly other cancers linked to solar UV exposure.

Sources of data: This narrative review draws on published scientific articles and material designed to assist identifying strategies to protect workers from solar UV exposure.

Areas of agreement: Solar UV exposure can be harmful. Wavelengths in the UVB range are more effective in causing erythema and DNA damage. Solar UV is the main source of vitamin D for most people. Primary and secondary prevention for skin cancer can potentially eliminate these risks but the evidence for effectiveness is limited.

Areas of controversy: Potential health benefits of UV exposure, particularly for reduced cancer risk. Determining and communicating optimal exposure to maximize health benefits. The risk of non-melanoma skin cancers may be more than doubled for some workers in temperate latitudes.

Areas timely for developing research: Exposure-response epidemiological studies; studies of the health benefits of occupational UV exposure; studies of the effectiveness of intervention strategies to prevent skin cancer. Use of low-cost UV sensors in workplaces.

背景:工作场所暴露于太阳紫外线(UV)会导致恶性黑色素瘤和非黑色素瘤皮肤癌。越来越多的证据表明,太阳紫外线照射对降低患其他癌症的风险有益。地球表面的紫外线辐射强度取决于纬度,但即使是在北欧国家,暴露在户外工作的紫外线强度也足以导致皮肤癌。生长点:对职业性太阳紫外线照射的健康风险和益处的认识较差。已经确定了降低皮肤癌风险的措施,雇主应该认识到他们有责任积极管理这些风险。有证据表明,与太阳紫外线照射有关的乳腺癌、卵巢癌和结直肠癌以及其他癌症的风险可能会降低。数据来源:本叙述性综述借鉴了已发表的科学文章和材料,旨在帮助确定保护工人免受太阳紫外线照射的策略。同意的领域:太阳紫外线照射是有害的。UVB范围内的波长在引起红斑和DNA损伤方面更有效。太阳紫外线是大多数人维生素D的主要来源。皮肤癌的一级和二级预防可以潜在地消除这些风险,但有效性的证据有限。争议领域:紫外线照射的潜在健康益处,特别是降低癌症风险。确定和沟通最佳暴露,以最大限度地提高健康效益。温带地区的一些工人患非黑色素瘤皮肤癌的风险可能会增加一倍以上。适时开展研究的领域:暴露-反应流行病学研究;职业性紫外线照射对健康的益处的研究;预防皮肤癌的干预策略的有效性研究。在工作场所使用低成本的紫外线传感器。
{"title":"Workplace exposure to UV radiation and strategies to minimize cancer risk.","authors":"J W Cherrie,&nbsp;M P C Cherrie","doi":"10.1093/bmb/ldac019","DOIUrl":"https://doi.org/10.1093/bmb/ldac019","url":null,"abstract":"<p><strong>Background: </strong>Workplace exposure to solar ultraviolet (UV) causes malignant melanoma and non-melanoma skin cancer. The evidence for beneficial effects of solar UV exposure in reducing the risks for other cancers is increasing. The intensity of UV radiation at the Earth's surface is dependent on latitude, but even in northern European countries exposure can be high enough for outdoor work to cause skin cancer.</p><p><strong>Growing points: </strong>Awareness of the health risks and benefits of occupational solar UV exposure is poor. Actions to reduce the risk of skin cancer have been identified and employers should recognize their responsibility to actively manage these risks. There is evidence for reduced risks for breast, ovarian and colorectal cancer and possibly other cancers linked to solar UV exposure.</p><p><strong>Sources of data: </strong>This narrative review draws on published scientific articles and material designed to assist identifying strategies to protect workers from solar UV exposure.</p><p><strong>Areas of agreement: </strong>Solar UV exposure can be harmful. Wavelengths in the UVB range are more effective in causing erythema and DNA damage. Solar UV is the main source of vitamin D for most people. Primary and secondary prevention for skin cancer can potentially eliminate these risks but the evidence for effectiveness is limited.</p><p><strong>Areas of controversy: </strong>Potential health benefits of UV exposure, particularly for reduced cancer risk. Determining and communicating optimal exposure to maximize health benefits. The risk of non-melanoma skin cancers may be more than doubled for some workers in temperate latitudes.</p><p><strong>Areas timely for developing research: </strong>Exposure-response epidemiological studies; studies of the health benefits of occupational UV exposure; studies of the effectiveness of intervention strategies to prevent skin cancer. Use of low-cost UV sensors in workplaces.</p>","PeriodicalId":9280,"journal":{"name":"British medical bulletin","volume":"144 1","pages":"45-56"},"PeriodicalIF":6.7,"publicationDate":"2022-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744745/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10417482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
A review of COVID vaccines: success against a moving target. COVID - 19疫苗综述:成功应对移动目标
IF 6.7 2区 医学 Q1 Medicine Pub Date : 2022-12-12 DOI: 10.1093/bmb/ldac025
S H Chong, L A Burn, T K M Cheng, I S Warr, J C Kenyon

Background: Multiple vaccine platforms against COVID-19 have been developed and found safe and efficacious at a record speed. Although most are effective, they vary in their ease of production and distribution, their potential speed of modification against new variants, and their durability of protection and safety in certain target groups.

Sources of data: Our discussion is based on published reports of clinical trials and analyses from national and global health agencies.

Areas of agreement: The production of neutralizing antibodies against the viral spike protein is protective, and all vaccines for which published data exist have been found to be effective against severe disease caused by the viral strain they target.

Areas of controversy: The degree to which vaccines protect against emerging variants, moderate disease and asymptomatic infection remains somewhat unclear.

Growing points: Knowledge of the duration of protection and its decay is increasing, and discussions of booster frequency and target strains are ongoing.

Areas timely for developing research: The global effort to combat transmission and disease continues to rely upon intense epidemiological surveillance, whilst real-world data and clinical trials shape vaccination schedules and formulae.

背景:针对COVID-19的多种疫苗平台已被开发出来,并以创纪录的速度被发现安全有效。虽然大多数都是有效的,但它们在生产和分发的难易程度、针对新变种的潜在修改速度以及它们在某些目标群体中的保护持久性和安全性方面各不相同。数据来源:我们的讨论基于已发表的临床试验报告以及国家和全球卫生机构的分析。达成一致的领域:产生针对病毒刺突蛋白的中和抗体具有保护作用,所有已发表数据的疫苗都被发现对其所针对的病毒株引起的严重疾病有效。争议领域:疫苗在多大程度上预防新出现的变种、中度疾病和无症状感染仍不清楚。生长点:关于保护持续时间及其衰减的知识正在增加,关于增强频率和目标应变的讨论正在进行中。及时开展研究的领域:全球防治传播和疾病的努力继续依赖于密切的流行病学监测,而实际数据和临床试验则决定了疫苗接种时间表和配方。
{"title":"A review of COVID vaccines: success against a moving target.","authors":"S H Chong,&nbsp;L A Burn,&nbsp;T K M Cheng,&nbsp;I S Warr,&nbsp;J C Kenyon","doi":"10.1093/bmb/ldac025","DOIUrl":"https://doi.org/10.1093/bmb/ldac025","url":null,"abstract":"<p><strong>Background: </strong>Multiple vaccine platforms against COVID-19 have been developed and found safe and efficacious at a record speed. Although most are effective, they vary in their ease of production and distribution, their potential speed of modification against new variants, and their durability of protection and safety in certain target groups.</p><p><strong>Sources of data: </strong>Our discussion is based on published reports of clinical trials and analyses from national and global health agencies.</p><p><strong>Areas of agreement: </strong>The production of neutralizing antibodies against the viral spike protein is protective, and all vaccines for which published data exist have been found to be effective against severe disease caused by the viral strain they target.</p><p><strong>Areas of controversy: </strong>The degree to which vaccines protect against emerging variants, moderate disease and asymptomatic infection remains somewhat unclear.</p><p><strong>Growing points: </strong>Knowledge of the duration of protection and its decay is increasing, and discussions of booster frequency and target strains are ongoing.</p><p><strong>Areas timely for developing research: </strong>The global effort to combat transmission and disease continues to rely upon intense epidemiological surveillance, whilst real-world data and clinical trials shape vaccination schedules and formulae.</p>","PeriodicalId":9280,"journal":{"name":"British medical bulletin","volume":"144 1","pages":"12-44"},"PeriodicalIF":6.7,"publicationDate":"2022-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10783783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
The use of long head biceps tendon autograft for massive rotator cuff tears: a PRISMA compliant systematic review. 自体长头二头肌腱移植治疗肩袖大面积撕裂:符合PRISMA的系统综述。
IF 6.7 2区 医学 Q1 Medicine Pub Date : 2022-12-12 DOI: 10.1093/bmb/ldac021
Rocco Aicale, Nicola Poeta, Eugenio Savarese, Giulio Bernardini, Francesco Oliva, Nicola Maffulli

Introduction: Rotator cuff tears (RCT) are a common cause of shoulder pain and disability, with massive RCT accounting for 10-40% of all rotator cuff tears.

Sources of data: A systematic search of PubMed and Scopus electronic databases was performed up to August 2022, and a total of 17 scientific articles were included in the present PRISMA compliant systematic review.

Areas of agreement: Understanding the geometric patterns in RCT is essential to achieve appropriate repositioning of the injured tendons in their anatomic location. The long head of the biceps tendon (LHBT) is usually exposed when defects of the anterolateral corner are present and can be easily used to augment rotator cuff repairs.

Areas of controversy: There are no definite guideline regarding the management of massive rotator cuff tears.

Growing points: The use of LHBT graft is safe and effective, but technically demanding. All studies were level IV articles of medium to high quality.

Areas timely for developing research: Prospective long term follow-up studies and randomized controlled trials are needed, adding imaging evaluation and appropriate clinical outcome measures at follow-up.

引言:肩袖撕裂(RCT)是肩部疼痛和残疾的常见原因,大量的RCT占所有肩袖撕裂的10-40%。数据来源:截至2022年8月,对PubMed和Scopus电子数据库进行了系统搜索,共有17篇科学文章被纳入符合PRISMA的系统综述。一致的领域:了解RCT中的几何模式对于实现受伤肌腱在其解剖位置的适当重新定位至关重要。当存在前外侧角缺陷时,二头肌腱(LHBT)的长头通常暴露出来,可以很容易地用于增强肩袖修复。争议的领域:对于巨大的肩袖撕裂的处理没有明确的指导方针。成长点:LHBT移植物的使用是安全有效的,但技术要求很高。所有研究均为中高质量的IV级文章。及时开展研究的领域:需要前瞻性的长期随访研究和随机对照试验,在随访中增加影像学评估和适当的临床结果测量。
{"title":"The use of long head biceps tendon autograft for massive rotator cuff tears: a PRISMA compliant systematic review.","authors":"Rocco Aicale,&nbsp;Nicola Poeta,&nbsp;Eugenio Savarese,&nbsp;Giulio Bernardini,&nbsp;Francesco Oliva,&nbsp;Nicola Maffulli","doi":"10.1093/bmb/ldac021","DOIUrl":"10.1093/bmb/ldac021","url":null,"abstract":"<p><strong>Introduction: </strong>Rotator cuff tears (RCT) are a common cause of shoulder pain and disability, with massive RCT accounting for 10-40% of all rotator cuff tears.</p><p><strong>Sources of data: </strong>A systematic search of PubMed and Scopus electronic databases was performed up to August 2022, and a total of 17 scientific articles were included in the present PRISMA compliant systematic review.</p><p><strong>Areas of agreement: </strong>Understanding the geometric patterns in RCT is essential to achieve appropriate repositioning of the injured tendons in their anatomic location. The long head of the biceps tendon (LHBT) is usually exposed when defects of the anterolateral corner are present and can be easily used to augment rotator cuff repairs.</p><p><strong>Areas of controversy: </strong>There are no definite guideline regarding the management of massive rotator cuff tears.</p><p><strong>Growing points: </strong>The use of LHBT graft is safe and effective, but technically demanding. All studies were level IV articles of medium to high quality.</p><p><strong>Areas timely for developing research: </strong>Prospective long term follow-up studies and randomized controlled trials are needed, adding imaging evaluation and appropriate clinical outcome measures at follow-up.</p>","PeriodicalId":9280,"journal":{"name":"British medical bulletin","volume":"144 1","pages":"76-89"},"PeriodicalIF":6.7,"publicationDate":"2022-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10409590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Corrigendum to: MicroRNA in osteoarthritis: physiopathology, diagnosis and therapeutic challenge. Corrigendum to:骨关节炎中的微RNA:生理病理、诊断和治疗挑战。
IF 6.7 2区 医学 Q1 Medicine Pub Date : 2022-12-12 DOI: 10.1093/bmb/ldz021
Antonio Oliviero, Giovanna Della Porta, Giuseppe M Peretti, Nicola Maffulli
{"title":"Corrigendum to: MicroRNA in osteoarthritis: physiopathology, diagnosis and therapeutic challenge.","authors":"Antonio Oliviero, Giovanna Della Porta, Giuseppe M Peretti, Nicola Maffulli","doi":"10.1093/bmb/ldz021","DOIUrl":"10.1093/bmb/ldz021","url":null,"abstract":"","PeriodicalId":9280,"journal":{"name":"British medical bulletin","volume":" ","pages":"90"},"PeriodicalIF":6.7,"publicationDate":"2022-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/bmb/ldz021","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37111398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
COVID-19 and the heart. COVID-19和心脏。
IF 6.7 2区 医学 Q1 Medicine Pub Date : 2022-12-12 DOI: 10.1093/bmb/ldac022
Roman Roy, Benedict McDonaugh, Kevin O'Gallagher

Background: There is evidence for a bi-directional relationship between COVID-19 and the cardiovascular (CV) system.

Source of data: Published literature.

Areas of agreement: Pre-existing heart failure (HF) increases the risk of mortality with COVID-19. CV complications are recognized, including increased rates of acute coronary syndromes, HF, arrhythmia and myocarditis. Drugs targeting the angiotensin system are safe and may provide prognostic benefit.

Areas of controversy: Vaccination as a cause of myocarditis remains a key area of contention.

Growing points: As the pandemic progresses, we are gaining more data about the long-term effects of COVID-19 on the CV system: long COVID, and medium-to-long-term increases in CV risk.

Areas timely for developing research: Large-scale longitudinal studies will shed light on long-term CV outcomes with COVID-19. Furthermore, the differential effects of COVID-19 variants on the CV system must be investigated.

背景:有证据表明COVID-19与心血管(CV)系统之间存在双向关系。数据来源:已发表文献。一致领域:先前存在的心力衰竭(HF)会增加COVID-19患者的死亡风险。心血管并发症是公认的,包括急性冠状动脉综合征、心衰、心律失常和心肌炎的发生率增加。靶向血管紧张素系统的药物是安全的,可能提供预后益处。争议领域:疫苗接种作为心肌炎的原因仍然是争论的关键领域。随着大流行的进展,我们正在获得更多关于COVID-19对CV系统的长期影响的数据:长期COVID和中长期CV风险增加。及时开展研究的领域:大规模纵向研究将揭示COVID-19的长期CV结果。此外,必须研究COVID-19变体对CV系统的不同影响。
{"title":"COVID-19 and the heart.","authors":"Roman Roy,&nbsp;Benedict McDonaugh,&nbsp;Kevin O'Gallagher","doi":"10.1093/bmb/ldac022","DOIUrl":"https://doi.org/10.1093/bmb/ldac022","url":null,"abstract":"<p><strong>Background: </strong>There is evidence for a bi-directional relationship between COVID-19 and the cardiovascular (CV) system.</p><p><strong>Source of data: </strong>Published literature.</p><p><strong>Areas of agreement: </strong>Pre-existing heart failure (HF) increases the risk of mortality with COVID-19. CV complications are recognized, including increased rates of acute coronary syndromes, HF, arrhythmia and myocarditis. Drugs targeting the angiotensin system are safe and may provide prognostic benefit.</p><p><strong>Areas of controversy: </strong>Vaccination as a cause of myocarditis remains a key area of contention.</p><p><strong>Growing points: </strong>As the pandemic progresses, we are gaining more data about the long-term effects of COVID-19 on the CV system: long COVID, and medium-to-long-term increases in CV risk.</p><p><strong>Areas timely for developing research: </strong>Large-scale longitudinal studies will shed light on long-term CV outcomes with COVID-19. Furthermore, the differential effects of COVID-19 variants on the CV system must be investigated.</p>","PeriodicalId":9280,"journal":{"name":"British medical bulletin","volume":"144 1","pages":"4-11"},"PeriodicalIF":6.7,"publicationDate":"2022-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619476/pdf/ldac022.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10766363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Call for emergency action to limit global temperature increases, restore biodiversity, and protect health. 呼吁采取紧急行动,限制全球气温上升,恢复生物多样性,保护健康。
IF 6.7 2区 医学 Q1 Medicine Pub Date : 2022-09-22 DOI: 10.1093/bmb/ldab020
Lukoye Atwoli, Abdullah H Baqui, Thomas Benfield, Raffaella Bosurgi, Fiona Godlee, Stephen Hancocks, Richard Horton, Laurie Laybourn-Langton, Carlos Augusto Monteiro, Ian Norman, Kirsten Patrick, Nigel Praities, Marcel G M Olde Rikkert, Eric J Rubin, Peush Sahni, Richard Smith, Nick Talley, Sue Turale, Damián Vázquez
Editor in Chief, East African Medical Journal; Editor in Chief, Journal of Health, Population and Nutrition; Editor in Chief, Danish Medical Journal; Editor in Chief, PLOS Medicine; Editor in Chief, The BMJ; Editor in Chief, British Dental Journal; Editor in Chief, The Lancet; Senior Adviser, UK Health Alliance on Climate Change; Editor in Chief, Revista de Saúde Pública; Editor in Chief, International Journal of Nursing Studies; Interim Editor in Chief, CMAJ; Executive Editor, Pharmaceutical Journal; Editor in Chief, Dutch Journal of Medicine; Editor in Chief, NEJM; Editor in Chief, National Medical Journal of India; Chair, UK Health Alliance on Climate Change; Editor in Chief, Medical Journal of Australia; Editor in Chief, International Nursing Review; and Editor in Chief, Pan American Journal of Public Health
{"title":"Call for emergency action to limit global temperature increases, restore biodiversity, and protect health.","authors":"Lukoye Atwoli,&nbsp;Abdullah H Baqui,&nbsp;Thomas Benfield,&nbsp;Raffaella Bosurgi,&nbsp;Fiona Godlee,&nbsp;Stephen Hancocks,&nbsp;Richard Horton,&nbsp;Laurie Laybourn-Langton,&nbsp;Carlos Augusto Monteiro,&nbsp;Ian Norman,&nbsp;Kirsten Patrick,&nbsp;Nigel Praities,&nbsp;Marcel G M Olde Rikkert,&nbsp;Eric J Rubin,&nbsp;Peush Sahni,&nbsp;Richard Smith,&nbsp;Nick Talley,&nbsp;Sue Turale,&nbsp;Damián Vázquez","doi":"10.1093/bmb/ldab020","DOIUrl":"https://doi.org/10.1093/bmb/ldab020","url":null,"abstract":"Editor in Chief, East African Medical Journal; Editor in Chief, Journal of Health, Population and Nutrition; Editor in Chief, Danish Medical Journal; Editor in Chief, PLOS Medicine; Editor in Chief, The BMJ; Editor in Chief, British Dental Journal; Editor in Chief, The Lancet; Senior Adviser, UK Health Alliance on Climate Change; Editor in Chief, Revista de Saúde Pública; Editor in Chief, International Journal of Nursing Studies; Interim Editor in Chief, CMAJ; Executive Editor, Pharmaceutical Journal; Editor in Chief, Dutch Journal of Medicine; Editor in Chief, NEJM; Editor in Chief, National Medical Journal of India; Chair, UK Health Alliance on Climate Change; Editor in Chief, Medical Journal of Australia; Editor in Chief, International Nursing Review; and Editor in Chief, Pan American Journal of Public Health","PeriodicalId":9280,"journal":{"name":"British medical bulletin","volume":"143 1","pages":"30-34"},"PeriodicalIF":6.7,"publicationDate":"2022-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494251/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39404992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of drugs used for 'assisted dying'. 用于“协助死亡”的药物的有效性和安全性。
IF 6.7 2区 医学 Q1 Medicine Pub Date : 2022-07-09 DOI: 10.1093/bmb/ldac009
Ana Worthington,Ilora Finlay,Claud Regnard
BACKGROUND'Assisted dying' is practiced in some European countries and US states. Legislation suggests that there exists an easily prescribed drug which consistently brings about death quickly and painlessly. Evidence from jurisdictions where 'assisted dying' is practiced, however, reveals that hastening patient death is not so simple.SOURCES OF DATAThis report is a collation of assisted suicide and euthanasia drug protocols published by the Canadian Association of MAiD Assessors and Providers and the Royal Dutch Medical Association, annual data reports from the USA and Canada and relevant academic publications pertaining to methods of 'assisted dying' in the USA, Belgium, Canada and Switzerland.AREAS OF AGREEMENTA wide variety of lethal drug combinations are used for people who want their life ended, and the prevalence of complications and failures in intentionally ending life suggest that 'assisted dying' applicants are at risk of distressing deaths.AREAS OF CONTROVERSYThe efficacy and safety of 'assisted dying' drugs are currently difficult to assess, as clinician reporting is often very low.GROWING POINTSThe findings from this report reveal that little attention has been given to the problem of unmonitored prescribing and administering of lethal drug combinations, whose mode of action is unclear.AREAS TIMELY FOR DEVELOPING RESEARCHIn order to properly assess the efficacy and safety of 'assisted dying', a more thorough means of data collection regarding the drugs used must be implemented and research is urgently needed into their mode of action.
“辅助死亡”在一些欧洲国家和美国各州实行。立法表明,存在一种容易开处方的药物,它总是迅速而无痛地导致死亡。然而,来自实施“协助死亡”的司法管辖区的证据表明,加速病人的死亡并没有那么简单。数据来源本报告整理了加拿大MAiD评估人员和提供者协会和荷兰皇家医学协会发表的协助自杀和安乐死药物协议,美国和加拿大的年度数据报告以及美国,比利时,加拿大和瑞士有关“协助死亡”方法的相关学术出版物。达成一致的领域各种各样的致命药物组合被用于想要结束生命的人,而故意结束生命的并发症和失败的普遍存在表明,“协助死亡”的申请人面临着痛苦死亡的风险。争议领域“辅助死亡”药物的有效性和安全性目前很难评估,因为临床医生的报告通常很低。这份报告的发现表明,致命药物组合的处方和使用不受监督的问题几乎没有得到重视,这些药物的作用方式尚不清楚。及时开展研究的领域为了正确评估“辅助死亡”的有效性和安全性,必须实施一种更彻底的关于所使用药物的数据收集方法,并且迫切需要研究它们的作用模式。
{"title":"Efficacy and safety of drugs used for 'assisted dying'.","authors":"Ana Worthington,Ilora Finlay,Claud Regnard","doi":"10.1093/bmb/ldac009","DOIUrl":"https://doi.org/10.1093/bmb/ldac009","url":null,"abstract":"BACKGROUND'Assisted dying' is practiced in some European countries and US states. Legislation suggests that there exists an easily prescribed drug which consistently brings about death quickly and painlessly. Evidence from jurisdictions where 'assisted dying' is practiced, however, reveals that hastening patient death is not so simple.SOURCES OF DATAThis report is a collation of assisted suicide and euthanasia drug protocols published by the Canadian Association of MAiD Assessors and Providers and the Royal Dutch Medical Association, annual data reports from the USA and Canada and relevant academic publications pertaining to methods of 'assisted dying' in the USA, Belgium, Canada and Switzerland.AREAS OF AGREEMENTA wide variety of lethal drug combinations are used for people who want their life ended, and the prevalence of complications and failures in intentionally ending life suggest that 'assisted dying' applicants are at risk of distressing deaths.AREAS OF CONTROVERSYThe efficacy and safety of 'assisted dying' drugs are currently difficult to assess, as clinician reporting is often very low.GROWING POINTSThe findings from this report reveal that little attention has been given to the problem of unmonitored prescribing and administering of lethal drug combinations, whose mode of action is unclear.AREAS TIMELY FOR DEVELOPING RESEARCHIn order to properly assess the efficacy and safety of 'assisted dying', a more thorough means of data collection regarding the drugs used must be implemented and research is urgently needed into their mode of action.","PeriodicalId":9280,"journal":{"name":"British medical bulletin","volume":"71 9","pages":"15-22"},"PeriodicalIF":6.7,"publicationDate":"2022-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138508252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
期刊
British medical bulletin
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1